Conference Coverage

PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan


 

REPORTING FROM ACC 19

Pages

Recommended Reading

­­ADT harms likely limited to men with CV comorbidities
MDedge Internal Medicine
What comes first with SGLT2 inhibitors – diabetes or heart failure?
MDedge Internal Medicine
Heart failure outcomes are worse in select HIV-infected individuals
MDedge Internal Medicine
Infective endocarditis isn’t what it used to be
MDedge Internal Medicine
Forget what you learned about infective endocarditis
MDedge Internal Medicine
Five pitfalls in optimizing medical management of HFrEF
MDedge Internal Medicine
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
MDedge Internal Medicine
FDA approves new valsartan generic
MDedge Internal Medicine
FDA: Programmable heart failure device approved
MDedge Internal Medicine
Clinicians, CMS confer over heart failure–readmission penalty
MDedge Internal Medicine

Related Articles